• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素泵治疗 2 型糖尿病时达到接近正常基础血糖控制所需的基础率数量。

The number of basal rates required to achieve near-normal basal glucose control in pump-treated type 2 diabetes.

机构信息

Diabetes Care Center, Salinas, California 93901, USA.

出版信息

Diabetes Technol Ther. 2012 Oct;14(10):900-3. doi: 10.1089/dia.2012.0104. Epub 2012 Jul 30.

DOI:10.1089/dia.2012.0104
PMID:22845649
Abstract

BACKGROUND

It has been reported that most pump-treated patients with type 2 diabetes require only two or fewer basal rates. Using daily continuous glucose monitoring (CGM)-directed titration, this premise was re-evaluated at near-normal glycemic control.

PATIENTS AND METHODS

Thirty subjects who were insulin-naive (n = 10), on basal insulin (n = 10), or on basal-bolus insulin therapy (n=10) ate a fixed diet. The basal rate was started as a single rate and then adjusted to a basal glucose goal of 70-130 mg/dL. The insulin-to-carbohydrate ratio (ICR) (in g/U) was adjusted to 2-4-h postmeal CGM glucose goal of 80-120% of premeal glucose.

RESULTS

The mean (SE) CGM basal glucose was 99.9 (4.9) mg/dL, and 4.5% (1.4%) of the readings were <70 mg/dL. The mean 2-4-h postmeal glucose was 113.3% (4.8%) of the premeal glucose. Only six subjects (20%) required two basal rates, while the remainder needed only one. The mean (SE) dosing relationships were as follows: total basal dose (TBD) (in U/day) = 0.226(0.018) × weight (in kg); TBD (in U/day) = 0.339(0.012) × total daily dose (TDD) (in U/day); ICR (in g/U) = 126(8)/TBD (in U/day); and ICR (in g/U) = 365(14)/TDD (in U/day).

CONCLUSIONS

This study confirms that one basal rate is adequate for the majority of subjects with type 2 diabetes. The mathematical proportionality between dosing factors closely agrees with those obtained in CGM-titrated pump-treated type 1 diabetes but differs from those derived from clinical studies in which insulin titration was based on infrequent self-monitored plasma glucose testing and while on an unstructured diet.

摘要

背景

据报道,大多数接受胰岛素输注治疗的 2 型糖尿病患者只需设定两种或更少的基础率。在接近正常血糖控制的情况下,使用连续血糖监测(CGM)指导的滴定法对这一前提进行了重新评估。

患者和方法

30 名从未使用过胰岛素(n=10)、使用基础胰岛素(n=10)或使用基础-餐时胰岛素治疗(n=10)的患者进食固定饮食。基础率设定为单一剂量,然后调整至 70-130mg/dL 的基础血糖目标。胰岛素与碳水化合物的比值(ICR)(g/U)调整为餐后 2-4 小时 CGM 血糖目标为餐前血糖的 80-120%。

结果

平均(SE)CGM 基础血糖为 99.9(4.9)mg/dL,4.5%(1.4%)的读数低于 70mg/dL。餐后 2-4 小时的平均血糖为餐前血糖的 113.3%(4.8%)。只有 6 名患者(20%)需要两种基础率,其余患者只需一种。平均(SE)给药关系如下:总基础剂量(TBD)(U/天)=0.226(0.018)×体重(kg);TBD(U/天)=0.339(0.012)×总日剂量(TDD)(U/天);ICR(g/U)=126(8)/TBD(U/天);ICR(g/U)=365(14)/TDD(U/天)。

结论

本研究证实,大多数 2 型糖尿病患者只需设定一种基础率。剂量因素之间的数学比例与 CGM 滴定的胰岛素输注治疗 1 型糖尿病中获得的结果非常吻合,但与基于频繁自我监测血浆葡萄糖检测和非结构化饮食的胰岛素滴定的临床研究中获得的结果不同。

相似文献

1
The number of basal rates required to achieve near-normal basal glucose control in pump-treated type 2 diabetes.胰岛素泵治疗 2 型糖尿病时达到接近正常基础血糖控制所需的基础率数量。
Diabetes Technol Ther. 2012 Oct;14(10):900-3. doi: 10.1089/dia.2012.0104. Epub 2012 Jul 30.
2
Carbohydrate-to-insulin ratio is estimated from 300-400 divided by total daily insulin dose in type 1 diabetes patients who use the insulin pump.在使用胰岛素泵的 1 型糖尿病患者中,碳水化合物与胰岛素的比例是根据 300-400 除以总日胰岛素剂量来估计的。
Diabetes Technol Ther. 2012 Nov;14(11):1077-80. doi: 10.1089/dia.2012.0109.
3
How much do I give? Reevaluation of insulin dosing estimation formulas using continuous glucose monitoring.我应该给多少剂量?使用连续血糖监测重新评估胰岛素剂量估算公式。
Endocr Pract. 2010 May-Jun;16(3):428-32. doi: 10.4158/EP09308.OR.
4
Rate of Change of Premeal Glucose Measured by Continuous Glucose Monitoring Predicts Postmeal Glycemic Excursions in Patients With Type 1 Diabetes: Implications for Therapy.通过连续血糖监测测定的餐前血糖变化率可预测1型糖尿病患者的餐后血糖波动:对治疗的启示。
J Diabetes Sci Technol. 2018 Jan;12(1):76-82. doi: 10.1177/1932296817725756. Epub 2017 Sep 4.
5
How much do I give? Dose estimation formulas for once-nightly insulin glargine and premeal insulin lispro in type 1 diabetes mellitus.我应该给多少剂量?1 型糖尿病患者中每晚一次甘精胰岛素和餐前胰岛素赖脯氨酸的剂量估算公式。
Endocr Pract. 2012 May-Jun;18(3):382-6. doi: 10.4158/EP11312.OR.
6
Minimal reduction in insulin dosage with pramlintide therapy when pretreatment near-normal glycemia is established and square-wave meal bolus is used.当建立了治疗前血糖接近正常且使用方波餐时大剂量胰岛素的情况时,使用普兰林肽治疗可使胰岛素剂量最小程度降低。
Endocr Pract. 2009 Apr;15(3):229-33. doi: 10.4158/EP.15.3.229.
7
A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: bolus dosing.对1型糖尿病患者在接近正常血糖控制水平时胰岛素给药建议的前瞻性评估:大剂量给药
J Diabetes Sci Technol. 2007 Jan;1(1):42-6. doi: 10.1177/193229680700100107.
8
Insulin pump therapy in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimen.胰岛素泵治疗 2 型糖尿病患者,采用简单的胰岛素给药方案,安全改善血糖控制。
Diabetes Technol Ther. 2010 Aug;12(8):627-33. doi: 10.1089/dia.2010.0034.
9
A 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injections.一项为期16周的开放标签、多中心试点研究,评估胰岛素泵疗法在使用每日多次注射血糖控制不佳的2型糖尿病患者中的效果。
J Diabetes Sci Technol. 2011 Jul 1;5(4):887-93. doi: 10.1177/193229681100500410.
10
Effect of miglitol as an add-on to bolus insulin on postprandial glycemic excursions in type 2 diabetes patients assessed by continuous glucose monitoring.通过连续血糖监测评估米格列醇作为餐时胰岛素的附加疗法对 2 型糖尿病患者餐后血糖波动的影响。
Diabetes Technol Ther. 2012 May;14(5):423-9. doi: 10.1089/dia.2011.0188. Epub 2012 Feb 8.

引用本文的文献

1
Cost-effectiveness of Simple Insulin Infusion Devices Compared to Multiple Daily Injections in Uncontrolled Type 2 Diabetics in the United States Based on a Simulation Model.基于模拟模型比较简单胰岛素输注装置与多次每日注射在美国未控制的2型糖尿病患者中的成本效益
J Health Econ Outcomes Res. 2018 Aug 22;6(1):84-95. doi: 10.36469/9789. eCollection 2018.
2
Insulin Pump Therapy for Patients With Type 2 Diabetes Mellitus: Evidence, Current Barriers, and New Technologies.胰岛素泵治疗 2 型糖尿病患者:证据、当前障碍和新技术。
J Diabetes Sci Technol. 2021 Jul;15(4):901-915. doi: 10.1177/1932296820928100. Epub 2020 Jun 1.
3
A Clinical Overview of Insulin Pump Therapy for the Management of Diabetes: Past, Present, and Future of Intensive Therapy.
胰岛素泵治疗糖尿病的临床概述:强化治疗的过去、现在与未来
Diabetes Spectr. 2019 Aug;32(3):194-204. doi: 10.2337/ds18-0091.
4
Improved glycaemic control and treatment satisfaction with a simple wearable 3-day insulin delivery device among people with Type 2 diabetes.在 2 型糖尿病患者中,使用简单的可穿戴 3 天胰岛素输送装置可改善血糖控制和治疗满意度。
Diabet Med. 2018 Oct;35(10):1448-1456. doi: 10.1111/dme.13708. Epub 2018 Jul 5.
5
A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes.1型糖尿病成人持续皮下胰岛素输注(CSII)胰岛素给药公式综述
Curr Diab Rep. 2016 Sep;16(9):83. doi: 10.1007/s11892-016-0772-0.
6
Misled by the Morning "Fasting" Plasma Glucose.被清晨“空腹”血糖误导
J Diabetes Sci Technol. 2015 May 13;9(6):1342-5. doi: 10.1177/1932296815586425.
7
Novel simple insulin delivery device reduces barriers to insulin therapy in type 2 diabetes: results from a pilot study.新型简易胰岛素给药装置降低2型糖尿病胰岛素治疗的障碍:一项试点研究的结果
J Diabetes Sci Technol. 2015 May;9(3):581-7. doi: 10.1177/1932296815570709. Epub 2015 Feb 9.
8
Diabetes: insulin pump therapy for type 2 diabetes mellitus.糖尿病:胰岛素泵治疗 2 型糖尿病。
Nat Rev Endocrinol. 2014 Nov;10(11):647-9. doi: 10.1038/nrendo.2014.142. Epub 2014 Aug 12.